 |
3 Diseases |  |
1 Trial |
|
1 Trial |  |
5 News |  |
- | CD19 targeted CAR-T / Southwest Hospital
Trial completion date, Trial primary completion date, CAR T-Cell Therapy: A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (clinicaltrials.gov) - Jun 25, 2019
P1/2, N=45, Recruiting, Sponsor: Southwest Hospital, China
Trial completion date: Dec 2019 --> Dec 2023 | Trial primary completion date: Dec 2018 --> Dec 2022
- | CD19 targeted CAR-T / Southwest Hospital
Trial primary completion date, CAR T-Cell Therapy: A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (clinicaltrials.gov) - Jan 23, 2018
P1/2, N=45, Recruiting, Sponsor: Southwest Hospital, China
Trial completion date: Dec 2019 --> Dec 2023 | Trial primary completion date: Dec 2018 --> Dec 2022 Trial primary completion date: Dec 2017 --> Dec 2018
- CD19 targeted CAR-T / Southwest Hospital
Phase classification, CAR T-Cell Therapy: A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (clinicaltrials.gov) - Nov 11, 2015
P1/2, N=45, Recruiting, Sponsor: Southwest Hospital, China
Trial primary completion date: Dec 2017 --> Dec 2018 Phase classification: P1 --> P1/2
- CD19 targeted CAR-T / Southwest Hospital
Enrollment open, CAR T-Cell Therapy: A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (clinicaltrials.gov) - Jun 15, 2015
P1, N=45, Recruiting, Sponsor: Southwest Hospital, China
Phase classification: P1 --> P1/2 Active, not recruiting --> Recruiting
- CD19 targeted CAR-T / Southwest Hospital
New P1 trial, CAR T-Cell Therapy: A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (clinicaltrials.gov) - Jan 29, 2015
P1, N=45, Active, not recruiting, Sponsor: Southwest Hospital, China